Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02594111 · ClinicalTrials.gov registry record · Phase 4
Colchicine in Percutaneous Coronary Intervention
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 714
- Enrollment target
NCT02594111: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT02594111 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 714 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02594111, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 714 participants
- Enrollment target
Study Summary
Inflammation in the arteries of the heart may increase the risk of cardiac death. The proposed research seeks to identify the potential beneficial role of a safe anti-inflammatory medication, colchicine, on reducing damage caused by opening up a blockage in the arteries of the heart. With its quick onset of action and excellent safety profile, colchicine may have the potential to reduce risk of major adverse events related to the heart. This research also seeks to better understand the role of neutrophils, the most common type of inflammatory white blood cell in the body, when there is damage to the heart.
Interventions
- DRUG Colchicine vs Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 714 participants |
| Start Date | 2013-05-30 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02594111
The ClinicalTrials.gov registry entry for NCT02594111 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 714 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colchicine vs Placebo is the first listed.
NCT02594111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02594111 about?
NCT02594111 is a clinical study titled "Colchicine in Percutaneous Coronary Intervention". Inflammation in the arteries of the heart may increase the risk of cardiac death. The proposed research seeks to identify the potential beneficial role of a safe anti-inflammatory medication, colchicine, on reducing damage caused by opening up a blockage in the arteries of the heart. With its quick ...
What is the current status of trial NCT02594111?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 714 participants. The study started on 2013-05-30. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02594111?
The interventions under investigation include: Colchicine vs Placebo (DRUG).
Who is sponsoring clinical trial NCT02594111?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.